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Chapter 4
Years of life lost due to influenza-attributable mortality
in older adults in the Netherlands: a competing risks
approach
The contents of this chapter have been published in the American Journal of Epidemiology:
Years of life lost due to influenza-attributable mortality in older adults in the Netherlands:
a competing risks approach
Scott A. McDonald, Maarten van Wijhe, Liselotte van Asten, Wim van der Hoek, Jacco Wallinga
American Journal of Epidemiology, Feb 6 2018
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Abstract
We estimated the influenza mortality burden in adults 60 years of age and older in the
Netherlands in terms of years of life lost, taking into account competing mortality risks.
Weekly laboratory surveillance data for influenza and other respiratory pathogens and weekly
extreme temperature served as covariates in Poisson regression models fitted to weekly
age-group specific mortality data for the period 1999/2000 through 2012/2013. Burden
for age-groups 60–64 through 85–89 years was computed as years of life lost before age
90 (YLL90) using restricted mean lifetimes survival analysis and accounting for competing
risks. Influenza-attributable mortality burden was greatest for persons aged 80–84 years, at
914 YLL90 per 100 000 persons [95% uncertainty interval (UI): 867, 963], followed by 85–89
years (787 YLL90 per 100 000; 95% UI: 741, 834). Ignoring competing mortality risks in the
computation of influenza-attributable YLL90 would lead to substantial over-estimation of
burden, from 3.5% for 60–64 years to 82% for persons aged 80–89 years at death. Failure
to account for competing mortality risks has implications for accuracy of disease burden
estimates, especially among persons aged 80 years and older. As the mortality burden borne
by the elderly is notably high, prevention initiatives may benefit from being redesigned to
more effectively prevent infection in the oldest age-groups.
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Introduction
Worldwide, infection with the influenza virus is responsible for considerable illness,
hospitalisation, and mortality, especially among older adults and elderly persons
(Simonsen et al., 2005, 2007), whose immune response is diminished compared with
younger adults (Bernstein et al., 1999; Parodi et al., 2011). The mortality burden
attributed to influenza virus infection is difficult to quantify from vital statistics
data, because (i) death certificates often do not list influenza as an underlying or
contributing cause when death is due to subsequent bacterial infection; (ii) influenza
infection may serve to worsen existing chronic respiratory or circulatory disease
so the chronic condition is entered as the underlying cause on the death certificate
(Glezen et al., 2000); and (iii) laboratory confirmation of influenza infection is seldom
done prior to death.
Given the public health significance of the large number of deaths presumed
to be caused by influenza (e.g., influenza was estimated to have caused 11%
of all deaths occurring in persons aged 65 years or older during the 2000–2009
influenza seasons in France (Bonmarin et al., 2015)) but are not registered as
such (Sprenger et al., 1993), statistical modelling methods have been used to infer
the true number of influenza-associated deaths from all-cause or cause-specific
mortality data. Numerous studies have adopted an ecological approach to the
estimation problem, by fitting generalised linear models that specify time series
of positive tests for influenza and other co-circulating respiratory pathogens from
virological surveillance systems as covariates, possibly adjusting for systematic
seasonal variation and other factors, to estimate the time series of influenza-
attributable mortality (Pitman et al., 2007; Goldstein et al., 2012; Van Asten et al.,
2012; Charu et al., 2013; Green et al., 2013; Hardelid et al., 2013; Kessaram et al., 2015;
Matias et al., 2016; Schanzer et al., 2013). Such methods exploit the seasonal patterns
in pathogen activity, and are successful in that—given the modelling assumptions—
the under-estimation in influenza mortality burden, if relying only on cause-of-death
coding, can be overcome.
Although mortality is an important epidemiological indicator of the impact of an
infectious disease in a population, the years of life lost (YLL) measure provides
a more precise quantitative measurement of the burden of influenza (and other
diseases) among the elderly than mortality incidence; with YLL, age at death (and
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so the expected remaining healthy life-years) is incorporated. The more prematurely
that death occurs, the higher the burden. Particularly for the elderly population,
for whom the prevalence of chronic multi-morbidity is high (Marengoni et al., 2008;
Van den Akker et al., 1998), it is vital to compute YLL for influenza treating death
from other causes as competing risks. The implicit assumption when calculating
YLL associated with a single cause of death such as influenza is that removing
this cause of death from the population would have no effect on the probability
of dying from other causes. However, this independence assumption is in general
not viable (Allignol et al., 2011; Andersen et al., 2012). To avoid over-estimation of
population-level total mortality burden, the YLL associated with each possible cause
of death should sum exactly to the YLL calculated on the basis of all-cause mortality,
and appropriate estimation methods are therefore required to ensure that cause-
specific YLL correctly acknowledges competing mortality risks (Lai and Hardy, 1999;
Andersen, 2013; Van Wijhe et al., 2016). The relevance of this issue grows with the
probability of death from other causes; i.e., with increasing age.
Thus, the principal objective of the current study is to estimate the weekly and
annual mortality burden from influenza in adults 60 years of age and older in terms
of YLL, taking into account competing mortality risks. Our secondary objective was
to compare this measure to ’standard’ YLL, which ignores competing mortality risks.
Methods
Study design and period
To model influenza-attributable deaths we considered mortality from any cause as
the primary dependent variable. We also considered two other, more specific, cause-
of-death categories: circulatory/respiratory causes and respiratory-only causes
(Charu et al., 2013; Van den Wijngaard et al., 2010). The latter was defined as cause of
death codes J00–J99 (ICD-10) or 460–519 (ICD-9), and the former was supplemented
with the circulatory disease codes I00–I99 (ICD-10) and 390–459 (ICD-9).
The study period was defined as the 1999/2000 through 2012/2013 influenza
seasons. Because death certificate coding practice changed from the beginning of
2013, leading to notable changes in distribution over certain cause-of-death code
categories, for the two more specific mortality outcomes the study period was
defined to end one season earlier, at 2011/2012.
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Data sources
All deaths in the Netherlands are registered with Statistics Netherlands. Weekly
mortality data with primary cause of death information, stratified by 5-year age-
group (60–64 through 80–84 years, and additionally 85+ years), were obtained for
the period 1999–2013. Causes of death were coded using ICD-10. Because influenza
circulates mainly during the winter months, seasons were defined as week 40 of a
given year through week 39 of the following year.
Routine weekly surveillance data on positive laboratory results for a range of res-
piratory pathogens have been reported since 1989. Between 17 and 21 laboratories
in the Netherlands submit weekly reports to a centralised database (the Weekly
Surveillance System of the Dutch Working Group on Clinical Virology (Dutch Work-
ing Group on Clinical Virology, 2016)). From these data, we counted PCR-confirmed
positive samples for the following viral and bacterial agents: influenza A/B, res-
piratory syncytial virus, rhinovirus, parainfluenza, and Mycoplasma pneumoniae. We
extracted data from 1999/2000 through 2012/2013, with seasons defined similarly
as for mortality.
Poisson regression modelling of influenza-attributable mortality
In common with the general ecological modelling approach used in previous
research (Pitman et al., 2007; Goldstein et al., 2012; Van Asten et al., 2012; Charu
et al., 2013; Green et al., 2013; Hardelid et al., 2013; Schanzer et al., 2013; Kessaram
et al., 2015; Matias et al., 2016), we assumed that seasonal variability in mortality
can be explained, in part, by temporal variation in the reporting incidence of various
respiratory pathogens. The proportion of mortality attributable to influenza can then
be determined after adjusting for the co-circulation of other pathogens and other
factors via linear regression techniques. We assumed additivity in this relationship
for simplicity (i.e., a given death cannot be caused by more than one respiratory
pathogen).
Separate Poisson regression models, with identity link function to enable an additive
interpretation of model coefficients, were fitted to the weekly mortality data for each
age-group. Laboratory virological surveillance data were not available stratified
by age; therefore each age-group specific regression model adjusted for the total
positive samples reported for the pathogen.
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Covariates. Besides influenza A (coded using separate variables for each season, to
capture seasonal variation in severity), the candidate pathogen covariates considered
were influenza B, respiratory syncytial virus, rhinovirus, Mycoplasma pneumoniae,
and parainfluenza. Temperature is known to be an important correlate of mortality
(Kunst et al., 1993; Donaldson and Keatinge, 2002), although the relationship is not
straightforward, as it may be that only periods of extreme cold and heat influence
the risk of death. We defined two covariates for temperature extremes, by first
calculating the average weekly temperatures (T , in degrees Celsius) from daily
temperatures recorded at the de Bilt (centrally located in the Netherlands) weather
station and made available online by the Royal Netherlands Meteorological Institute
(Royal Netherlands Meteorological Institute (KNMI), 2016), and then coding low
extreme temperature using the function max(0, 5 − T ) and high extreme as max(0,
T−17) (Van Asten et al., 2012). This coding effectively treats temperatures as extreme
if below 5C or above 17C.
Model selection. A defined model selection procedure was carried out for each age-
group separately. First, linear and quadratic terms were entered to model temporal
trends in mortality (and so avoid over-estimation of attribution to influenza or the
other pathogens). We term this the base model. We next considered the impact of
0- to 4-week lags between weekly surveillance reports of influenza A and B and
other co-circulating pathogens and mortality (Van Asten et al., 2012). Respiratory
pathogens were explored one at a time using a forward selection procedure: each
lagged covariate was added independently to the base model, with the lag associated
with the largest AIC reduction selected. Next, to the base model now augmented
with the selected lags for influenza A and B and the other respiratory pathogens,
low and high extreme temperature terms were specified, and trigonometric terms
were added to account for the assumed sinusoidal-shaped background mortality
(modelling seasonal variation due to other causes). Next, pathogen covariates with
negative coefficients were removed on grounds of biological implausibility (it is not
plausible that pathogen infection would decrease the risk of death). Finally, the
single influenza A term was replaced with 14 separate season-specific influenza
coefficients; if any of these coefficients were negative, the model was refitted after
removing these terms. Models were therefore fitted of the form:
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We use the index i to refer to the week of the study period, the index j to refer
to the pathogen, and the index s to refer to the season. Y is assumed to follow
a Poisson distribution. Yi is the observed number of deaths in week i, β0 is a
constant (or intercept) term; the next terms capture linear and quadratic temporal
trends with wi defined as the ith week in the study period. N is the total number
of seasons for which season-specific influenza A coefficient αs is non-negative, Zs,i
are the weekly laboratory reported positive influenza A samples within season s,
Xi,1...n are the weekly laboratory reported positive samples for up to n co-circulating
pathogens (i.e., model fit-based selection from: influenza B, respiratory syncytial
virus, rhinovirus, parainfluenza, and Mycoplasma pneumoniae), with potential lag
of tj weeks. Additional included terms are for extreme temperature: Thigh,i and
Tlow,i, and the two harmonic terms: sin ( 2pii52.143 ) and cos (
2pii
52.143 ). The same procedure
was applied to fit regression models to circulatory/respiratory and respiratory-
only underlying cause mortality data. We constructed 95% prediction intervals
(PIs) around predicted weekly influenza-attributable deaths using bootstrapping
methods.
Computation of years of life lost (YLL)
YLL are standardly defined as the number of cause-specific deaths multiplied by
the expected number of healthy life-years lost conditional on the age at death. This
residual life expectancy (LE) is defined as how long a person would expect to live
in an ideal world that is free of disease assuming access to health care. For instance,
the WHO Global Health Estimates projected LE values for 2050, citing a LE at birth
of 92 years (World Health Organization, 2013).
Andersen (2013) definition of YLL computed in a competing risk framework requires
estimation of cause-specific cumulative risks of death, which in turn requires age-
and/or time-specific cause-specific mortality data. Note that this approach differs
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from the ’standard’ YLL definition, in that the τ -restricted mean lifetime method
from survival analysis is used instead of adopting age-specific LE from life tables.
We defined τ = 90, so we effectively calculate YLL based on a LE of 90 years. We
denote this variant of YLL as ’YLL90’, which can be interpreted as the expected
number of life years lost before reaching the age of 90. To quantify the anticipated
over-estimation of mortality burden that would occur if competing mortality risks
were ignored, we compare YLL90 to YLL computed based on Kaplan-Meier survival
curves (see Supplementary information to Chapter 4).
The estimation of YLL90 was carried out using a simulation procedure applied to
conditional survival functions defined for ’cohorts’ consisting of all persons within
each age-group at death (see Supplementary information to Chapter 4 for a detailed
description). Cumulative mortality incidence curves were then constructed for (i)
influenza-attributable deaths, and (ii) all other causes of death, and YLL90 for each
cause category calculated accordingly (Supplementary information to Chapters 2
and 4; see also Andersen (2013); Van Wijhe et al. (2016)). This simulation procedure
was repeated 1000 times, with the uncertainty inherent in the resulting age-group
specific distributions of influenza-attributable YLL90 combined with the 95% PIs for
predicted influenza-attributable deaths, yielding 95% uncertainty intervals (UIs) for
YLL90.
Within each iteration, YLL90 was calculated for each age-group and season, sim-
ulating conditional survival functions based on the weekly predicted number of
influenza-attributable deaths derived from the corresponding fitted Poisson models
and the national population estimates (see Supplementary information toChapter 4
for further details).
Outcomes and statistical analysis
We present the weekly and annual YLL90 due to influenza-attributable mortality
both in absolute terms, and also as the proportion of annual total YLL90 within
the entire outcome category (all-cause, circulatory/respiratory, or respiratory only);
thus considering deaths from causes other than influenza as competing risks. The
latter measure—proportion of total YLL90—permits declining secular trends in
mortality to be taken into account. In addition, to allow comparisons of mortality
burden between age-groups, we report YLL90 per 100 000. This measure controls for
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differences in age-group population size (and thus adjusts for demographic change;
i.e., the growing and ageing Dutch population (National Kompass Volksgezondheid
(NKV), 2016)) so that influenza mortality burden can be meaningfully compared
across age-groups. Finally, inter-season variability was quantified as the standard
deviation of the YLL90 per 100 000 measure. All modelling was conducted in the
R statistical programming environment, version 3.2.0 (R Development Core Team,
2015).
Results
The total number of influenza-attributable deaths in persons aged 60+ years ranged
from 40 to 3330 over season (1.3% of all deaths) and varied by age-group, with
the highest influenza mortality rate estimated for the 85+ years age-group (see
Supplementary Table 4.3 and Supplementary Figure 4.3). Models fitted to more
specific cause-of-death data (i.e., respiratory/circulatory underlying causes, and
respiratory causes only) showed similar temporal patterns, but with smaller absolute
numbers (Supplementary Figures 4.4 and 4.5).
Years of life lost before age 90
Influenza-attributable mortality burden exhibited considerable seasonal variability,
with YLL90 ranging from 480 to 30 680 across seasons within the study period
(Table 4.1). The 85–89 years age-group, although contributing the largest estimated
number of influenza-associated deaths (1.7% of the cumulative total registered
deaths in this age-group over the study period), did not incur the largest absolute
influenza-attributable burden; this was observed for the 80–84 years group, with
across-season average YLL90 of 2992 (Table 4.2).
Between 0.04% and 2.37% of the total YLL90 per season in persons aged 60–89 years
was attributed to influenza (Table 4.1 and Figure 4.1). This proportion measure,
which adjusts for any secular changes in overall mortality risk, tended to decrease
over the study period. The 85–89 years age-group was responsible for the largest
age-group specific share of the total mortality burden (1.61%) (Table 4.2).
Estimates using more specific cause-of-death data—respiratory/circulatory under-
lying causes and respiratory causes only—were comparable to the all-cause results,
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Table 4.1: Total and influenza-attributable YLL90 for persons aged 60–89 years,
the Netherlands, seasons 1999/2001 through 2012/2013. Shown are the total and
the proportion of total YLL90 attributable to influenza, and influenza-attributable
YLL90 per 100 000 stratified by 5-year age-group at death. Temporal variability in
YLL90 per 100 000 per age-group is indicated by the standard deviation (SD). Data
is based on all-cause mortality. Only point estimates are shown.





60–64 65–69 70–74 75–79 80–84 85–89
1999/2000 1 343 300 14 580 1.09% 430 50 60 997 1176 1333
2000/2001 1 334 700 3340 0.24% 18 170 25 374 45 57
2001/2002 1 347 400 25 860 1.92% 437 540 914 1617 1598 746
2002/2003 1 331 800 24 120 1.81% 168 681 995 862 1894 1235
2003/2004 1 295 400 30 680 2.37% 330 782 1172 1248 2057 1610
2004/2005 1 306 100 28 370 2.17% 99 486 1143 1363 2349 1464
2005/2006 1 263 900 10 500 0.83% 12 166 395 517 945 539
2006/2007 1 230 100 4180 0.34% 24 320 24 252 55 63
2007/2008 1 258 000 5890 0.47% 345 4 0 13 171 647
2008/2009 1 258 800 8020 0.64% 427 10 8 362 91 469
2009/2010 1 289 900 480 0.04% 3 42 0 0 13 19
2010/2011 1 261 100 2370 0.19% 3 0 2 58 314 291
2011/2012 1 297 900 8530 0.66% 10 108 245 229 580 812
2012/2013 1 320 800 21 170 1.60% 120 543 401 158 1503 1730
Inter-season variability (SD) 175 281 464 543 831 578
YLL: Years of life lost.
in showing similar decreasing temporal trends in the proportion of total YLL90
attributed to influenza (Supplementary Figures 4.6 and 4.7), and similar rankings
of this proportion over age-group. However, lower absolute YLL90 and YLL90
per 100 000 rates (Supplementary Tables 4.4 and 4.5) were obtained, due to smaller
numbers of influenza-attributed deaths.
Influenza-attributable YLL90 per 100 000 persons for all-cause mortality is depicted
in Supplementary Figure 4.8. The YLL90 rates for the younger age-groups (i.e., 60–
64, 65–69 years) varied widely across seasons of the study period, but variation in
the burden was even more pronounced for persons aged 80–89 years (Figure 4.2
and Table 4.1). A similar age pattern was observed if YLL90 is calculated using
more specific cause-of-death data (Supplementary Figures 4.9 and 4.10). When
standardising for age-group population size and aggregating over season, the
highest burden (YLL90 of 914 per 100 000; 95% UI: 867, 963) was observed for the
80–84 years age-group, with the second highest burden (787 per 100 000; 95% UI:
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Figure 4.1: Contribution of influenza to total YLL90 by age-group, the
Netherlands, seasons 1999/2000 through 2012/2013. Proportion of total YLL90
attributable to influenza based on all-cause mortality data, aggregated to 4-week
intervals for the period 1999/2000 through 2012/2013. Each age-group is shown as
a separate panel: (A) 60–64 years; (B) 65–69 years; (C) 70–74 years; (D) 75–79 years;
(E) 80–84 years; and (F) 85–89 years.
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Table 4.2: Comparison of age-group specific influenza-attributable YLL90 in the
Netherlands, seasons 1999/2000 through 2012/2013. Shown are averages over
seasons 1999/2000 through 2012/2013. Data is based on all-cause mortality.












60–64 1493 0.67% 173 [152, 199] 1544 0.69% 179 [157, 205]
65–69 1980 0.82% 279 [255, 303] 2116 0.87% 297 [272, 323]
70–74 2243 0.84% 385 [357, 415] 2492 0.93% 427 [396, 460]
75–79 2658 1.00% 575 [540, 613] 3106 1.17% 671 [629, 716]
80–84 2992 1.50% 914 [867, 963] 4095 2.03% 1236 [1173, 1303]
85–89 2053 1.61% 787 [741, 834] 5055 3.70% 1878 [1782, 1981]
All [60–89] 1 13 433 1.03% 423 [412, 435] 18 468 1.40% 573 [559, 589]
YLL: Years of life lost; UI: uncertainty interval.
1 Influenza-attributable YLL90 or YLL for individual age-groups do not sum to the value for All [60–89], as the latter
was computed using the aggregated age-group 60–89 years.
2 YLL based on Kaplan-Meier Survival, and so does not account for competing mortality risks.
741, 834) for persons aged 85–89 years (Table 4.2). YLL90 for these two age-groups
is notably high, as YLL90 for the age-group with next highest burden, 75–79 years,
was 37% lower, at 575 per 100 000 [95% UI: 540, 613]. Ignoring competing mortality
risks tended to over-estimate the overall mortality burden. For persons aged 60–64
years at death, YLL computed based on Kaplan-Meier survival curves yielded an
overall 3.5% higher total mortality burden attributed to influenza compared with
YLL90 (Table 4.2). However, the extent of over-estimation increased with age; for
persons aged 80–89 years, over-estimation was 82%.
Discussion
In terms of the estimated number of influenza-attributable deaths the highest burden
was observed for persons aged 85 years and older. However, the YLL90 measure
provides an alternative view of mortality burden by taking into account age at death
and competing risks of death from other causes. Of the total YLL90 calculated from
all-cause mortality, the greatest proportion attributable to influenza—1.61%—was
also among persons aged 85–89 years. The next youngest age-groups (80–84 years
and 75–79 years) had the second and third largest influenza-attributable shares of
the mortality burden. However, the age-standardised mortality burden measure
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Figure 4.2: Median influenza-attributable YLL90 per 100 000 by season and age-
group, the Netherlands, seasons 1999/2000 through 2012/2013. Data is based on all-
cause mortality, aggregated by season, and plotted separately by 5-year age-group.
YLL90 per 100 000 localised the highest mortality burden to the 80–84 years age-
group, followed by the 85–89 years age-group.
Our estimates of the proportion of total YLL90 per season in 60- to 89-year-olds that
is due to influenza, although small on average (ranging from 0.04% to 2.37% across
seasons; Table 4.1), are also lower than if YLL is computed ignoring competing
mortality risks. Age-group specific burden varied between the two measures; for
persons aged 80–89 years, the latter YLL measure yielded a notably higher (82%)
estimated mortality burden. This suggests that competing risks for mortality in




The age group-specific influenza-attributable proportion ranged from an across-
season average of 0.67% for 60- to 64-year-olds to an average of 1.61% for 85-
to 89-year-olds (Table 4.2). However, averaging influenza-attributable mortality
burden obscures variation over time. There was also substantial variation in
age-group specific YLL90 per 100 000, particularly for persons 80 years and older
(Figure 4.2), which suggests that variation in season severity may disproportionally
affect the most aged segment of the population (Lofgren et al., 2007). This variation
reflects a complex interplay between the circulating virus strain distribution, vaccine
mismatch, and degree of natural immunity (Viboud and Epstein, 2016).
The temporal patterns and magnitude of influenza-attributable mortality we ob-
tained were comparable to previous statistical modelling exercises conducted using
Netherlands data for wider age-groups. Van Asten et al. (2012) estimated that 1.5%
of total deaths in 65-year-olds and over in the period 1999–2007 was due to influenza
A; we observed 1.4% of total deaths due to influenza A/B for the same age group
in the longer period 1999 through 2013. Van den Wijngaard et al. (2010) calculated
annual age-specific YLL for the period 1999 through 2010 (however, not taking com-
peting mortality risks into account and using lower LE norms), and reported total
YLL per season that varied from 0 to approximately 18 000 for person aged 75+
years. Our estimated YLL90 range for the same age-group over our study period
was 102 to 17 630, which is necessarily lower due to the incorporation of competing
mortality risks in the YLL90 calculation.
Consistent with previous research (Van den Wijngaard et al., 2010; Wielders et al.,
2012), we observed a relatively low influenza mortality burden among older adults—
0.04% of total YLL90 based on all-cause deaths—for the 2009/20010 pandemic year.
Other than for 2009/2010, for which 100% of influenza A samples were subtype
H1N1 and for 2003/2004, for which 100% were H3N2 (Darvishian et al., 2017), there
was no clear correspondence between seasonal total YLL90 and dominant circulating
virus type.
We used all-cause mortality in the main analysis. Because influenza infection
plays a larger role for certain causes of death, one can also estimate burden
based on more specific cause-of-death categories. Supplementary analyses using
circulatory/respiratory and respiratory-only mortality data were largely consistent
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with the results based on all-cause mortality. Although the estimated influenza-
attributable YLL90 and YLL90 per 100 000 were lower, the greater mortality burden
for persons 80–89 years was replicated.
Attribution of influenza-caused mortality via Poisson regression is technically chal-
lenging and is consequently subject to several limitations (Simonsen and Viboud,
2012). First, through inclusion of harmonic terms to capture seasonal patterns in
mortality unaccounted for by the included covariates, we effectively made the as-
sumption that the impact of these unmeasured influences is static across seasons.
This could lead to over- or under-estimation of the associations between the activity
of other pathogens and mortality in a given season; alternative regression modelling
techniques may improve model fit (Muscatello et al., 2014). Related to this issue,
by fitting a single, time-invariant regression coefficient for each circulating pathogen
other than influenza A, the number of weekly deaths attributable to these pathogens
was constrained to be a constant proportion of the reported positive tests. Finally,
we assumed that there were no historical changes in testing/reporting that would
affect the laboratory surveillance data.
As age at death was available only at a granularity of five years, our method
randomly allocated an age at death for the calculation of cumulative mortality
incidence and YLL90. This led to lower precision in age-specific YLL90 than if the
exact age at death were known. The restricted mean lifetime approach requires
definition of a maximum attainable age. Using a higher limit, e.g., 95 years, would
inflate the estimated absolute YLL90 and YLL90 per 100 000 values, but age group-
specific proportions would not change appreciably.
Our quantitative estimation of the mortality burden due to influenza in the Nether-
lands over a 14-season analysis period indicates that the greatest burden, adjusting
for population size, is borne by persons aged 80 years and over, and is highest for the
80–84 age-group. The more aged segment of persons targeted by the Dutch national
influenza prevention programme has a historically higher vaccination uptake (75+
years: 85% in 2008) than younger eligible persons (65–74 years: 73% in 2008) (Statis-
tics Netherlands (CBS), 2011), but uptake does not translate directly into protection.
Although the single large randomized trial conducted to date yielded a vaccine ef-
ficacy (VE) of 59% [95% CI: 20%, 79%] for the youngest (60–69 years) decade of our
study population (Govaert et al., 1994), evidence regarding VE of the (inactivated)
109
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flu vaccine for persons aged 70 years and over is lacking. As the Dutch residual
life expectancy upon reaching one’s 80th birthday is about nine years, substantial
mortality burden could be averted by preventing influenza in the elderly. Given
the large observed degree of inter-season variability in mortality burden borne by
the oldest age-groups—related to the strain distribution, vaccine mismatch (De Jong
et al., 2000), virus pathogenicity, vaccination coverage, and drivers of transmission—
the most vulnerable elderly may benefit from being targeted for further prevention
measures as supplement to routine flu vaccination.
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Supplementary information to Chapter 4
Chapter 4
Simulation of cumulative mortality curves conditional
on being alive at age y
Conditional survival functions (ie., conditional on being alive at age y) were defined
for ’cohorts’ constructed from all members of all age-groups at death. Entry to
follow-up for each cohort was defined as turning age 60 (i.e., y was set to 60 years).
Given the coarse age-granularity of the mortality data, age of death was simulated
within each five-year age interval by randomly sampling discrete ages at death from
a uniform distribution. For the oldest age-group we assumed a uniform distribution
between 85 and 89 years. The simplification of treating deaths occurring after τ =
90 years as occurring within the interval 85 to <90 has little impact, as relatively few
deaths were recorded in persons≥90 years: 16% of all deaths in those aged 60+ years
in the period 1999/2000 to 2012/2013 occurred at ≥90 years ((Statistics Netherlands
(CBS), 2016)).
After age of death was assigned, the season-cohort to which each individual
belonged (i.e., the season in which he/she turned 60 years old) could be determined.
For instance, persons dying at age 68 years entered follow-up on first day of the
season in which their 60th birthday fell (see Supplementary Figure 4.1 for simplified
example life trajectories plotted as a Lexis diagram), but follow-up was constrained
to begin no earlier than the beginning of the 1999/2000 season. Thus, for deaths
in the older age-groups in the earlier seasons, follow-up necessarily started at their
age in 1999/2000 (e.g., black trajectory, Supplementary Figure 4.1). Deaths were
actually simulated to fall within either the upper or lower ’Lexis triangle’ within a
given square of the season-by-age grid; this depended on the week of the season
in which the death was recorded. Thus, individuals who died at age a in season s
and who had a simulated life trajectory with end point in the lower Lexis triangle
were assigned to age cohort (a - 60) in season 0, where s = 0 for 1999/2000, s =
1 for 2000/2001, etc. Those whose simulated trajectory ended in the upper Lexis
triangle were assigned to age cohort (a - 60 + 1) in season 0. For individuals with
start of follow-up after season 0, assignment was to age cohort 60 in season (s - (a -
60)) (upper Lexis triangle or to age cohort 60 in season (s - (a - 60 - 1)) (lower Lexis
triangle). Next, total cohort membership at entry to follow-up for each age cohort
in 1999/2000 (and for each of the 13 cohorts of individuals turning 60 in seasons
2000/2001 through 2012/2013) was assigned based on the national age-specific
population size for the season. The latter was determined as the population on 1st
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January falling within the season ((Statistics Netherlands (CBS), 2016)). There is now











99/00   00/01   01/02   02/03   03/04   04/05   05/06   06/07   07/08
Season
Age
Supplementary Figure 4.1: Example of a Lexis diagram (2). Lexis diagram with
example trajectories for three individuals. The black and red individuals both died
at age 67; for the death in the 2006/2007 season, follow-up started at age 60, at the
beginning of season 1999/2000; for the person who died in 2004/2005, follow-up
began at age 62 in 1999/2000. The blue individual, who died at age 63 in season
2004/2005 could only be followed-up starting in 2000/2001, from age 60.
Computation of cause-specific YLL90
After constructing cause-specific cumulative mortality incidence curves (using the
Aalen-Johansen estimator) for each age/season cohort, for influenza and other
causes of death, YLL90 for each cumulative incidence curve corresponding to the
interval of interest, e.g. the incidence in a particular season multiplied by the period
between age at death and age 90 and the starting population size of the cohort (see
Andersen (2013) and Supplementary information to Chapter 2).
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Specifically, if τ0 is the age at entry to follow-up and τ is the maximum possible
lifespan in years, the expected years of life lost between age τ0 and age τ due to





where Fˆj(t) is the Aalen-Johansen estimator for the cause j cumulative mortality
incidence, and is the closed-form expression (where Sˆ is the Kaplan-Meier estimator,
dj,i is the number of deaths from cause j at time ti; ni is the number of persons at








The sum over each cause-specific YLL, Lj , and the Kaplan-Meier estimator, Sˆ, for






Ljτ0, τ = τ − τ0 (4.4)
The above equation states that the number of years of life lost between age τ0 and age
τ due to all causes j, plus the years of life lived, should equal the difference between
the starting cohort age and the maximum lifespan. This balance equation is what
differentiates the competing risk method for deriving cause-specific years of life lost
from a method using Kaplan-Meier (K-M) survival curves to estimate cause-specific
years of life lost. For each age/season cohort separately, we can therefore estimate
the number of years of life lost due to each cause j, while taking into account the
competing risk of mortality from other causes.
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Comparison of YLL90 with YLL derived from Kaplan-
Meier survival
We next defined years of life lost for a given cause, but ignoring competing mortality
risks; this we term Kaplan-Meier based years of life lost. This is comparable to the
’standard’ definition of YLL for a given cause (ie. disease, injury or condition), which
is calculated as remaining life expectancy at age of death. Summed ’standard’ YLL
calculated separately for a number of causes can be paradoxically greater than the
total YLL ’possible’ (when calculated for deaths from any cause).
In the Kaplan-Meier based YLL approach, the expected years of life lost (with respect





where the cumulative mortality incidence due to cause j4, Gˆj is estimated as one







Gˆj(t) = 1− Sˆj(t) (4.7)
where dj,i is the number of deaths from cause j at time ti and ni is the number of
persons at risk at time ti (in which deaths from other causes are considered censoring
events). Note that this definition of YLL will not satisfy the balance equation above.
To illustrate the difference between YLL90, and YLL based on Kaplan-Meier survival
calculated separately for influenza and for other causes of death, we graphically
compare cumulative incidence of mortality curves computed using the present com-
peting risk approach, to cumulative mortality curves computed based on Kaplan-
Meier survival (1 - K-M estimate). As an example, consider the cohort of 80-year-
olds commencing follow-up at the beginning of season 1999/2000 (Supplementary
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Influenza deaths: competing risks method
Deaths from other cause: competing risks method        
Influenza deaths: Kaplan−Meier method
Deaths from other cause: Kaplan−Meier method
Supplementary Figure 4.2: Example cumulative mortality incidence curves.
Influenza mortality computed using the Aalen-Johansen estimator is compared with
the Kaplan-Meier method. Starting cohort is a cohort of 80-year-olds in season
1999/2000. Data is based on all-cause mortality data.
Figure 4.2). This cumulative mortality incidence plot indicates that the K-M method
slightly over-estimates influenza-attributable mortality, and thus would over-estimate
YLL due to influenza. The curve for cumulative mortality attributable to influenza
is upwardly biased when competing mortality risks from other causes are ignored
(because death from other causes is incorrectly treated as a censoring event, which
assumes that persons would still be at risk of dying from influenza had they been
followed-up longer), compared with when competing risks are taken into account.
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Supplementary Table 4.4: Competing risks versus Kaplan-Meier using
circulatory/respiratory mortality, the Netherlands, seasons 1999/2000 through
2011/2012. Comparison of age-group specific influenza-attributable YLL90 with YLL
based on Kaplan-Meier survival. Influenza-attributable YLL90 was derived using
circulatory/respiratory mortality and averaged over seasons 1999/2000 through
2011/2012. Values in square brackets are 95% uncertainty intervals.












60–64 1159 0.53% 145 [124, 167] 1196 0.55% 149 [128, 172]
65–69 1138 0.47% 170 [150, 191] 1208 0.50% 181 [159, 203]
70–74 1693 0.62% 295 [267, 324] 1864 0.69% 324 [293, 356]
75–79 2230 0.86% 483 [445, 520] 2616 1.00% 566 [522, 609]
80–84 2005 1.03% 630 [589, 672] 2652 1.35% 825 [771, 880]
85–89 1077 1.04% 442 [407, 477] 2462 2.27% 988 [913, 1062]
All (60–89) 9302 0.72% 302 [292, 313] 11998 0.93% 387 [374, 400]
YLL: Years of life lost.
Supplementary Table 4.5: Competing risks versus Kaplan-Meier using respiratory
mortality, the Netherlands, seasons 1999/2000 through 2011/2012. Comparison of
age-group specific influenza-attributable YLL90 with YLL based on Kaplan-Meier
survival. Influenza-attributable YLL90 was derived using circulatory/respiratory
mortality and averaged over seasons 1999/2000 through 2011/2012. Values in
square brackets are 95% uncertainty intervals.












60–64 464 0.22% 59 [42, 77] 478 0.22% 61 [44, 79]
65–69 584 0.24% 87 [65, 111] 619 0.26% 92 [69, 117]
70–74 1088 0.40% 190 [160, 222] 1190 0.44% 207 [175, 243]
75–79 1155 0.45% 249 [214, 285] 1366 0.53% 294 [252, 337]
80–84 1346 0.70% 423 [378, 473] 1798 0.92% 558 [499, 625]
85–89 791 0.76% 325 [286, 367] 1783 1.66% 716 [634, 809]
All (60–89) 5434 0.42% 176 [165, 188] 7245 0.56% 232 [218, 248]
























































































































































































Supplementary Figure 4.3: Poisson regression model fit to weekly all-cause
mortality, the Netherlands, seasons 1999/2000 through 2012/2013. Mortality rates
per 10 000 persons (circles) for each age-group are shown as separate panels. The




























































































































































































































Supplementary Figure 4.4: Poisson regression model fit to weekly mortality from
a circulatory or respiratory underlying cause, the Netherlands, seasons 1999/2000
through 2012/2013. Mortality rates per 10 000 persons (circles) for each age-group are















































































































































































































































































































































































































































Supplementary Figure 4.5: Poisson regression model fit to weekly mortality from
respiratory underlying causes only, the Netherlands, seasons 1999/2000 through
2012/2013. Mortality rates per 10 000 persons (circles) for each age-group are shown
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Supplementary Figure 4.6: Contribution of influenza to total YLL90 by age-
group using mortality from a circulatory or respiratory underlying cause, the
Netherlands, seasons 1999/2000 through 2012/2013. Proportion of total YLL90
attributable to influenza aggregated to 4-week intervals for the period 1999/2000
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Supplementary Figure 4.7: Contribution of influenza to total YLL90 by age-group
using mortality from respiratory underlying causes only, the Netherlands, seasons
1999/2000 through 2012/2013. Proportion of total YLL90 attributable to influenza
aggregated to 4-week intervals for the period 1999/2000 through 2012/2013. Each
































































Supplementary Figure 4.8: Influenza-attributable YLL90 per 100 000 by age-group,
the Netherlands, seasons 1999/2000 through 2012/2013. Data is based on all-
cause mortality and aggregated over 4-week intervals. Age-group-specific mortality




































































Supplementary Figure 4.9: Influenza-attributable YLL90 per 100 000 by age-
group using mortality from a circulatory or respiratory underlying cause, the
Netherlands, seasons 1999/2000 through 2012/2013. Data is based on mortality from
a circulatory or respiratory underlying cause and aggregated over 4-week intervals.




























































Supplementary Figure 4.10: Influenza-attributable YLL90 per 100 000 by age-
group using mortality from respiratory underlying causes only, the Netherlands,
seasons 1999/2000 through 2012/2013. Data is based on mortality from respiratory
underlying causes only and aggregated over 4-week intervals. Age-group-specific
mortality burden is represented as stacked coloured regions.
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